Influence of Follicle Stage on Artificial Ovary Outcome Using Fibrin As a Matrix

Total Page:16

File Type:pdf, Size:1020Kb

Influence of Follicle Stage on Artificial Ovary Outcome Using Fibrin As a Matrix Human Reproduction, Vol.31, No.2 pp. 427–435, 2016 Advanced Access publication on November 30, 2015 doi:10.1093/humrep/dev299 ORIGINAL ARTICLE Reproductive biology Influence of follicle stage on artificial ovary outcome using fibrin as a matrix M.C. Chiti1, M.M. Dolmans1,2,*, R. Orellana1, M. Soares1,2, F. Paulini1, J. Donnez3, and C.A. Amorim1 Downloaded from https://academic.oup.com/humrep/article/31/2/427/2379968 by guest on 13 December 2020 1Poˆle de Recherche en Gyne´cologie, Institut de Recherche Expe´rimentale et Clinique, Universite´ Catholique de Louvain, Avenue Mounier 52, bte. B1.52.02, 1200 Brussels, Belgium 2Gynecology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium 3Society for Research into Infertility, Brussels, Belgium *Correspondence address. Poˆle de Recherche en Gyne´cologie, Institut de Recherche Expe´rimentale et Clinique, Universite´ Catholique de Louvain, Avenue Mounier 52, bte B1.52.02, 1200 Brussels, Belgium. Tel: +32-2-764-5237; Fax: +32-2-764-9507; E-mail: marie-madeleine. [email protected] Submitted on July 15, 2015; resubmitted on October 19, 2015; accepted on November 6, 2015 study question: Do primordial-primary versus secondary follicles embedded inside a fibrin matrix have different capabilities to survive and grow after isolation and transplantation? summaryanswer: Mouse primordial-primary follicles showed a lower recovery rate than secondary follicles, but both were able to grow. what is known already: Fresh isolated mouse follicles and ovarian stromal cells embedded in a fibrin matrix are capable of surviving and developing after short-term autografting. study design, size, duration: In vivo experimental model using 11 donor Naval Medical Research Institute (NMRI) mice and 11 recipient severe combined immunodeficiency (SCID) mice. Both ovaries from all NMRI mice were mechanically disrupted and primordial- primary and secondary follicles were isolated with ovarian stromal cells. They were then encapsulated in a fibrin matrix composed of 12.5 mg/ml of fibrinogen (F12.5) and 1 IU/ml of thrombin (T1) (F12.5/T1), and grafted to the inner part of the peritoneum of SCID mice for 2 and 7 days. participants/materials, setting, methods: This study was conducted at the Gynecology Research Unit, Universite´ Catholique de Louvain. All materials were used to conduct histological (H-E staining) and immunohistochemical (Ki67, TUNEL) analyses. mainresultsandtheroleofchance:Although all grafted fibrin clots were recovered, the follicle recovery rate on day 2 was 16 and 40% for primordial-primary and secondary follicles respectively, while on day 7, it was 6 and 28%. The secondary group showed a significantly higher recovery rate than the primordial-primary group (23%, P-value ,0.001). Follicles found in both groups were viable, as demonstrated by live/dead assays, and no difference was observed in the apoptosis rate between groups, as evidenced by TUNEL. Their growth to further stages was confirmed by Ki67 immunostaining. limitations, reasons for caution: As demonstrated by our results, secondary follicles appear to be more likely to survive and develop than primordial-primary follicles in a fibrin matrix after both periods of grafting. These findings may also be attributed to the specific features of the fibrin matrix, which could benefit larger follicles, but not smaller follicles. wider implications of the findings: This study is essential to understanding possible impairment caused by factors such as the isolation procedure or fibrin matrix composition to the survival and development of different follicle stages. It therefore provides the basis for further investigations with longer periods of grafting. study funding/competing interest(s): This study was supported by grants from the Fonds National de la Recherche Scien- tifique de Belgique (grant Te´le´vie No. 7.4578.14 and 7.4627.13, grant 5/4/150/5 awarded to Marie-Madeleine Dolmans), Fonds Spe´ciaux de Recherche, Fondation St Luc, the Foundation Against Cancer, and the Region Wallone (Convention N86519-OVART) and donations from Mr Pietro Ferrero, Baron Fre`re and Viscount Philippe de Spoelberch. None of the authors have any competing interests to declare. Key words: artificial ovary / isolated pre-antral follicles / allografting / mouse / fibrin matrix & The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: [email protected] 428 Chiti et al. Introduction In recent years, different research teams have been developing the concept of an artificial ovary (Amorim et al., 2009; Shikanov et al., 2009, 2011; Hornick et al., 2012; Vanacker et al., 2012, 2014; Donnez and Dolmans, 2013; Luyckx et al., 2013a, 2014; Laronda et al., 2014; Smith et al., 2014; Rajabzadeh et al., 2015) with the aim of restoring fer- tility in patients who cannot undergo transplantation of frozen-thawed ovarian tissue due to the risk of reintroducing malignant cells (Dolmans et al., 2010; Luyckx et al., 2013b; Donnez and Dolmans, 2015). To this end, a murine model was used to test the feasibility of encapsulating isolated murine pre-antral follicles in different natural polymers. A previ- Downloaded from https://academic.oup.com/humrep/article/31/2/427/2379968 by guest on 13 December 2020 ous study by our group showed that 20% of murine pre-antral follicles could be detected after isolation, encapsulation in an alginate matrix and autografting for 1 week (Vanacker et al., 2014). Despite these en- Figure 1 Different developmental stages of isolated follicles. Light microscopy pictures of isolated follicles at 10 × magnification: (a) prim- couraging results, alginate was found to have a number of limitations, ordial-primary (PP) follicles; (b) secondary (S) follicles. such as a low degradation rate, poor bioadhesion to encapsulate ovarian stromal cells, and decreased vascularization inside the matrix. To overcome these drawbacks, Luyckx et al. (2013a) developed a Ethical approval fibrin scaffold after testing different combinations of fibrinogen and Guidelines for animal welfare were approved by the Committee on Animal thrombin. Using isolated mouse follicles encapsulated in a fibrin formula- Research of the Universite´ Catholique de Louvain. tion with low concentrations of fibrinogen and thrombin, Luyckx et al. (2014) reported a higher degradation rate of the matrix and a more active process of revascularization inside this scaffold. Probably Ovariectomy procedure because of this, they recovered a greater number of follicles after auto- Eleven female NMRI mice aged 6–25 weeks were used for this study. Animal grafting (32%) (Luyckx et al., 2014). Similarly to Vanacker et al. (2014), housing conditions were previously reported by Vanacker et al. (2012). All they also found a higher proportion of secondary follicles and even the procedures were carried out under laminar flow hoods using sterilized some antral follicles after 1 week of transplantation (Luyckx et al., materials. The ovaries were removed through a dorsal incision in anesthe- 2014). However, it is important to stress that before transplantation, tized mice (ketamine 75 mg/kg; Anesketin, Eurovet, Heusden Zolder, Belgium). Buprenorphine (0.1 mg/kg; Temgesic, Schering Plough, Kenil- Luyckx et al. (2014) observed that more than 50% of the follicles were worth, NJ, USA) was administered for analgesia. Soon after the ovariectomy at the secondary stage, which raised an important question: did primor- procedure, the mice were euthanized by CO2 asphyxiation. The ovaries dial and primary follicles grow to the secondary stage in 7 days, or were were kept in minimum essential medium + GlutamaxTM (MEM, Gibco, these secondary follicles found after grafting already at the secondary Belgium) at 48C until the isolation procedure. stage atthe moment of transplantation? If they were originally primordial- primary follicles, did we encounter faster growth, as suggested by Telfer and Zelinski (2013)? If they were secondary follicles, what happened to Isolation of pre-antral follicles and ovarian the population of primordial-primary follicles? These are very pertinent stromal cells questions if wetakeinto account the factthat the large majority of follicles Fatty tissuesurrounding theovaries wasremoved with surgicalscissors.In order isolated from human ovarian tissue are at the primordial-primary stage to isolate pre-antral follicles and ovarian stromal cells, we applied the protocol (Amorim et al., 2009). To address these crucial points, we investigated described by Vanacker et al. (2014). The ovaries were initially minced into frag- × the impact of the developmental stage of isolated follicles, primordial- ments of 0.5 0.5 mm with a tissue chopper (McIlwain Tissue Chopper, Mickle Laboratory, Guildford, UK) and transferred to 50-ml conical tubes primary or secondary, on their survival and growth after encapsulation containing Dulbecco’s phosphate-buffered saline medium (PBS 1X) without in a fibrin matrix and grafting. calcium and magnesium (Gibco, Life Technologies, Merelbeke, Belgium), sup- plemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, Bornem, Belgium). The suspension was pipetted several times to mechanically disrupt the tissue fragments and then transferredtoPetri dishesand investigated for fol- Materials and Methods licles under a stereomicroscope (Leica, Van Hopplynus Instruments, Brussels, Belgium). Over the course of one hour, isolated follicles were picked up Experimental design by two operators
Recommended publications
  • Creating an Artificial 3-Dimensional Ovarian Follicle Culture System
    micromachines Article Creating an Artificial 3-Dimensional Ovarian Follicle Culture System Using a Microfluidic System Mae W. Healy 1,2, Shelley N. Dolitsky 1, Maria Villancio-Wolter 3, Meera Raghavan 3, Alexandra R. Tillman 3 , Nicole Y. Morgan 3, Alan H. DeCherney 1, Solji Park 1,*,† and Erin F. Wolff 1,4,† 1 Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA; [email protected] (M.W.H.); [email protected] (S.N.D.); [email protected] (A.H.D.); [email protected] (E.F.W.) 2 Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA 3 Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA; [email protected] (M.V.-W.); [email protected] (M.R.); [email protected] (A.R.T.); [email protected] (N.Y.M.) 4 Pelex, Inc., McLean, VA 22101, USA * Correspondence: [email protected] † Solji Park and Erin F. Wolff are co-senior authors. Abstract: We hypothesized that the creation of a 3-dimensional ovarian follicle, with embedded gran- ulosa and theca cells, would better mimic the environment necessary to support early oocytes, both structurally and hormonally. Using a microfluidic system with controlled flow rates, 3-dimensional Citation: Healy, M.W.; Dolitsky, S.N.; two-layer (core and shell) capsules were created. The core consists of murine granulosa cells in Villancio-Wolter, M.; Raghavan, M.; 0.8 mg/mL collagen + 0.05% alginate, while the shell is composed of murine theca cells suspended Tillman, A.R.; Morgan, N.Y.; in 2% alginate.
    [Show full text]
  • Social Freezing: Pressing Pause on Fertility
    International Journal of Environmental Research and Public Health Review Social Freezing: Pressing Pause on Fertility Valentin Nicolae Varlas 1,2 , Roxana Georgiana Bors 1,2, Dragos Albu 1,2, Ovidiu Nicolae Penes 3,*, Bogdana Adriana Nasui 4,* , Claudia Mehedintu 5 and Anca Lucia Pop 6 1 Department of Obstetrics and Gynaecology, Filantropia Clinical Hospital, 011171 Bucharest, Romania; [email protected] (V.N.V.); [email protected] (R.G.B.); [email protected] (D.A.) 2 Department of Obstetrics and Gynaecology, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 3 Department of Intensive Care, University Clinical Hospital, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 4 Department of Community Health, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania 5 Department of Obstetrics and Gynaecology, Nicolae Malaxa Clinical Hospital, 020346 Bucharest, Romania; [email protected] 6 Department of Clinical Laboratory, Food Safety, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; [email protected] * Correspondence: [email protected] (O.N.P.); [email protected] (B.A.N.) Abstract: Increasing numbers of women are undergoing oocyte or tissue cryopreservation for medical or social reasons to increase their chances of having genetic children. Social egg freezing (SEF) allows women to preserve their fertility in anticipation of age-related fertility decline and ineffective fertility treatments at older ages. The purpose of this study was to summarize recent findings focusing on the challenges of elective egg freezing.
    [Show full text]
  • Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity
    International Journal of Molecular Sciences Review Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity Hyun-Woong Cho, Sanghoon Lee * , Kyung-Jin Min , Jin Hwa Hong , Jae Yun Song, Jae Kwan Lee , Nak Woo Lee and Tak Kim Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul 02841, Korea; [email protected] (H.-W.C.); [email protected] (K.-J.M.); [email protected] (J.H.H.); [email protected] (J.Y.S.); [email protected] (J.K.L.); [email protected] (N.W.L.); [email protected] (T.K.) * Correspondence: [email protected]; Tel.: +82-2-920-6773 Received: 9 October 2020; Accepted: 20 October 2020; Published: 21 October 2020 Abstract: Due to improvements in chemotherapeutic agents, cancer treatment efficacy and cancer patient survival rates have greatly improved, but unfortunately gonadal damage remains a major complication. Gonadotoxic chemotherapy, including alkylating agents during reproductive age, can lead to iatrogenic premature ovarian insufficiency (POI), and loss of fertility. In recent years, the demand for fertility preservation has increased dramatically among female cancer patients. Currently, embryo and oocyte cryopreservation are the only established options for fertility preservation in women. However, there is growing evidence for other experimental techniques including ovarian tissue cryopreservation, oocyte in vitro maturation, artificial ovaries, stem cell technologies, and ovarian suppression. To prevent fertility loss in women with cancer, individualized fertility
    [Show full text]
  • Preservation of Fertility in Patients with Cancer (Review)
    ONCOLOGY REPORTS 41: 2607-2614, 2019 Preservation of fertility in patients with cancer (Review) SOFÍA DEL-POZO-LÉRIDA1, CRISTINA SALVADOR2, FINA MARTÍNEZ-SOLER3, AVELINA TORTOSA3, MANUEL PERUCHO4,5 and PEPITA GIMÉNEZ-BONAFÉ1 1Department of Physiological Sciences, Physiology Unit, Faculty of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, 08907 Barcelona; 2Department of Gynecology, Gynecological Endocrinology and Reproduction Unit, Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona; 3Department of Basic Nursing, Faculty of Medicine and Health Sciences, Universitat de Barcelona, IDIBELL, L' Hospital et del Llobregat, 08907 Barcelona, Spain; 4Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, CA 92037, USA; 5Program of Predictive and Personalized Medicine of Cancer (PMPPC), of the Research Institute Germans Trias i Pujol (IGTP), Badalona, 08916 Barcelona, Spain Received January 18, 2019; Accepted March 6, 2019 DOI: 10.3892/or.2019.7063 Abstract. Survival rates in oncological patients have been techniques evaluated. Emerging techniques are promising, steadily increasing in recent years due to the greater effec- such as the cryopreservation in orthotopic models of ovarian tiveness of novel oncological treatments, such as radio- and or testicle tissues, artificial ovaries, or in vitro culture prior chemotherapy. However, these treatments impair the reproduc- to the autotransplantation of cryopreserved tissues. However, tive ability of patients, and may cause premature ovarian failure oocyte vitrification for female patients and sperm banking for in females and azoospermia in males. Fertility preservation male patients are considered the first line fertility preserva- in both female and male oncological patients is nowadays tion option at the present time for cancer patients undergoing possible and should be integrated as part of the oncological treatment.
    [Show full text]
  • Conference Abstracts
    Conference abstracts. IV International Symposium on Animal Biology of Reproduction, Oct. 17-20, 2012, Campinas, SP, Brazil. Advances in goat artificial ovary J.R. Figueiredo Laboratory of Manipulation of Oocytes and Preantral Follicles (LAMOFOPA), Faculty of Veterinary, State University of Ceara, Fortaleza, Ceara, Brazil. Background The majority of thousands of oocytes in the ovaries are small, non-growing and reside in preantral follicles (PFs). The development of a culture system for preantral follicle may be very useful for understanding the complex mechanism in folliculogenesis at early stages of development as wells as could offer a significant way for the propagation of livestock, including goats. The in vitro follicular culture aims to mimic what happens with a few pre- ovulatory follicles, which escapes from atresia and ovulate. For this reason, this technique is also known as “artificial ovary”. This abstract describes the results of a number of studies aimed to evaluate the effects of several substances on in vitro culture of caprine preantral follicles highlighting the many advances, limitations and prospects. Review Caprine PFs are usually cultured either in ovarian cortical slices or after isolation. Although IVC (in vitro culture) of PFs enclosed in cortical slices is practical, non-time-consuming, maintains three dimensional follicle architecture and preserves interactions between follicles and surrounding stroma cells, the cortical tissue may act as a barrier to IVC medium perfusion. Conversely, IVC of isolated PFs allows monitoring of individual follicles throughout the growing period, but is time-consuming, may be affected by the isolation procedure, demands a more sophisticated IVC system and is often applied to secondary and not to primordial and primary follicles.
    [Show full text]
  • Reproductionanniversary Review
    158 5 REPRODUCTIONANNIVERSARY REVIEW FERTILITY PRESERVATION Progress and prospects for developing human immature oocytes in vitro Evelyn E Telfer Institute of Cell Biology and Genes and Development Group CDBS, The University of Edinburgh, Edinburgh, UK Correspondence should be addressed to E E Telfer; Email: [email protected] This paper forms part of an anniversary issue on Fertility Preservation. The Guest Editor for this section was Professor Roger Gosden, College of William and Mary, Williamsburg, Virginia, USA Abstract Ovarian cryopreservation rapidly developed from basic science to clinical application and can now be used to preserve the fertility of girls and young women at high risk of sterility. Primordial follicles can be cryopreserved in ovarian cortex for long-term storage and subsequently autografted back at an orthotopic or heterotopic site to restore fertility. However, autografting carries a risk of re-introducing cancer cells in patients with blood-born leukaemias or cancers with a high risk of ovarian metastasis. For these women fertility restoration could only be safely achieved in the laboratory by the complete in vitro growth (IVG) and maturation (IVM) of cryopreserved primordial follicles to fertile metaphase II (MII) oocytes. Culture systems to support the development of human oocytes have provided greater insight into the process of human oocyte development as well as having potential applications within the field of fertility preservation. The technology required to culture human follicles is extremely challenging, but significant advances have been made using animal models and translation to human. This review will detail the progress that has been made in developing human in vitro growth systems and consider the steps required to progress this technology towards clinical application.
    [Show full text]
  • Reproductionanniversary Review
    158 5 REPRODUCTIONANNIVERSARY REVIEW FERTILITY PRESERVATION Construction and use of artificial ovaries Marie-Madeleine Dolmans1,2 and Christiani A Amorim1 1Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium and 2Gynecology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium Correspondence should be addressed to M-M Dolmans or C A Amorim; Email: [email protected] or [email protected] This paper forms part of an anniversary issue on Fertility Preservation. The Guest Editor for this section was Professor Roger Gosden, College of William and Mary, Williamsburg, Virginia, USA Abstract Increasing numbers of patients are now surviving previously fatal malignant diseases, so for women of childbearing age, fertility concerns are paramount once they are cured. However, the treatments themselves, namely chemo- and radiotherapy, can cause considerable damage to endocrine and reproductive functions, often leaving these women unable to conceive. When such gonadotoxic therapy cannot be postponed due to the severity of the disease or for prepubertal girls, the only way to preserve fertility is cryobanking their ovarian tissue for future use. Unfortunately, with some types of cancer, there is a risk of reimplanting malignant cells together with the frozen-thawed tissue, so it is not recommended. A safer approach involves grafting isolated preantral follicles back to their native environment inside a specially created transplantable artificial ovary for their protection. This bioengineered ovary must mimic the natural organ and therefore requires an appropriate scaffold to encapsulate not only isolated follicles, but also autologous ovarian cells, which are needed for follicles to survive and develop.
    [Show full text]
  • The Human Ovary and Future of Fertility Assessment in the Post-Genome Era
    International Journal of Molecular Sciences Review The Human Ovary and Future of Fertility Assessment in the Post-Genome Era Emna Ouni 1, Didier Vertommen 2 and Christiani A. Amorim 1,* 1 Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium 2 PHOS Unit, Institut de Duve, Université Catholique de Louvain, 1200 Brussels, Belgium * Correspondence: [email protected]; Tel.: +322-764-5287 Received: 30 July 2019; Accepted: 27 August 2019; Published: 28 August 2019 Abstract: Proteomics has opened up new avenues in the field of gynecology in the post-genome era, making it possible to meet patient needs more effectively and improve their care. This mini-review aims to reveal the scope of proteomic applications through an overview of the technique and its applications in assisted procreation. Some of the latest technologies in this field are described in order to better understand the perspectives of its clinical applications. Proteomics seems destined for a promising future in gynecology, more particularly in relation to the ovary. Nevertheless, we know that reproductive biology proteomics is still in its infancy and major technical and ethical challenges must first be overcome. Keywords: mass spectrometry; ovary; fertility; biomarkers; oocyte competence 1. Introduction Proteomics is an emerging discipline that involves studying the proteome, namely the gene expression of a cell, tissue or organism, through analyzing proteins and their subsequent translational modifications by mass spectrometry (MS). The proteomic bottom-up strategy (proteolytic peptide mixture analysis) is the most commonly used method for analysis of biological samples. Strategies applied to prepare proteins or more complex proteomic samples for MS analysis involve many steps, and in bottom-up proteomics, the protein constituent is first scaled down into peptides, either by chemical or enzymatic digestion, prior to MS analysis.
    [Show full text]
  • WOMEN in REPRODUCTIVE SCIENCE: Lessons From
    158 3 REPRODUCTIONFOCUS REVIEW WOMEN IN REPRODUCTIVE SCIENCE Lessons from bioengineering the ovarian follicle: a personal perspective Teresa K Woodruff Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Correspondence should be addressed to T K Woodruff; Email: [email protected] This paper forms part of a focus section on Women in Reproductive Science. The guest editor for this section was Professor Marilyn Renfree, Ian Potter Chair of Zoology, School of BioSciences, The University of Melbourne, Victoria, Australia Abstract The ovarian follicle and its maturation captivated my imagination and inspired my scientific journey – what we know now about this remarkable structure is captured in this invited review. In the past decade, our knowledge of the ovarian follicle expanded dramatically as cross-disciplinary collaborations brought new perspectives to bear, ultimately leading to the development of extragonadal follicles as model systems with significant clinical implications. Follicle maturation in vitro in an ‘artificial’ ovary became possible by learning what the follicle is fundamentally and autonomously capable of – which turns out to be quite a lot. Progress in understanding and harnessing follicle biology has been aided by engineers and materials scientists who created hardware that enables tissue function for extended periods of time. The EVATAR system supports extracorporeal ovarian function in an engineered environment that mimics the endocrine environment of the reproductive tract. Finally, applying the tools of inorganic chemistry, we discovered that oocytes require zinc to mature over time – a truly new aspect of follicle biology with no antecedent other than the presence of zinc in sperm. Drawing on the tools and ideas from the fields of bioengineering, materials science and chemistry unlocked follicle biology in ways that we could not have known or even predicted.
    [Show full text]
  • Artificial Ovaries Design
    Artificial Ovaries Design Created by: Meghan McGraw, ‘22 Chemical Engineering, Biomedical Engineering Edited by: Claire Kenny, ‘21 Materials Science and Engineering, Biomedical Engineering 2 This educational resource for high school audiences was developed as a project by Carnegie Mellon student, Meghan McGraw, for the course Experiential Learning through Projects, Section O, taught by Dr. Conrad Zapanta and Dr. Judith Hallinen during the summer of 2020. Editing and additional project development was completed by Carnegie Mellon student Claire Kenny. www.cmu.edu/gelfand www.cmu.edu/bme 3 CAUTION: If you are attempting an experiment, it is important to make sure that you are following all safety steps. All experiments should be completed with supervision of a adult. Weather permitting, we recommend taking messy experiments outside. Remember to wear safety gear like gloves, aprons, and goggles, especially for experiments with chemical reactions! The materials and information presented may be used for educational purposes as described in the Terms of Use at www.cmu.edu/gelfand and parents/legal guardians are responsible for taking all necessary safety precautions for the experiments. To the maximum extent allowed under law, Carnegie Mellon University is not responsible for any claims, damages or other liability arising from using the materials or conducting the experiments. Be SAFE and enjoy the modules! www.cmu.edu/gelfand www.cmu.edu/bme 4 Learning Goals 1. Demonstrate knowledge of basic ovarian anatomy and physiology. 2. Identify the causes and consequences of ovarian damage 3. Describe the stages of tissue engineering and identify how it can be used to solve infertility problems 4.
    [Show full text]
  • Fertility and Cancer
    Fertility and Cancer FS23 in a series providing the latest information for patients, caregivers and healthcare professionals. Highlights Introduction y Fertility describes the ability to conceive a Chemotherapy and radiation can cause “late” side biological child. Some cancers and some cancer effects that may appear months or years after treatments affect fertility in males and females. treatment has ended. One possible late effect is infertility, the inability to conceive a child without y The risk of infertility caused by cancer and its medical intervention. When first diagnosed with a treatment is based on several factors, including blood cancer, your primary concern may be your the type of cancer; the type, duration, and doses upcoming treatment and long-term survival. You of treatment; and the patient’s age at the start may not be thinking about whether you can or want of treatment. to have children in the future. However, information y Addressing fertility and sexual health is an about the potential effects of your treatment can help essential part of cancer treatment and follow-up you take steps to leave your options open, which care. It is important to talk with members of your includes conceiving a child after cancer treatment. oncology team before treatment begins about the potential effects of your treatment. This publication provides only general information about this topic. Speak with members of your y There are many options available to help you healthcare team about the specific effects of your preserve the ability to have biological children treatment and the fertility preservation options that are in the future.
    [Show full text]
  • Ovarian Systems Biology Michael K
    Spring 2020 – Systems Biology of Reproduction Lecture Outline – Ovarian Systems Biology Michael K. Skinner – Biol 475/575 CUE 418, 10:35-11:50 am, Tuesday & Thursday March 3, 2020 Week 8 Ovarian Systems Biology Cell Biology of the Ovary -Cell types/organization -Developmental stages (Folliculogenesis) -Atresia/apoptosis -Oogenesis Regulation of Folliculogenesis -Growth properties of ovarian follicles -Local production and action of growth factors -Growth regulations during development -Primordial follicle transition Endocrine Regulation of Tissue Function -Gonadotropin actions (Pituitary/Gonadal Axis) -Steroid production and action -Two cell theory modifications -Hormone actions during development Cell-Cell Interactions -Categorization of different cell-cell interactions in the ovary -Growth factor regulation follicle development -Oogenesis and systems biology Required Reading Bahr JM. (2018) Ovary, Overview. in: Encyclopedia of Reproduction 2nd Edition, Ed: MK Skinner. Elsevier. Vol 2: 3-7. REFERENCES Qi X, Yun C, Sun L, Xia J, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019 Aug;25(8):1225-1233. Ramly B, Afiqah-Aleng N, Mohamed-Hussein ZA. Protein-Protein Interaction Network Analysis Reveals Several Diseases Highly Associated with Polycystic Ovarian Syndrome. Int J Mol Sci. 2019 Jun 18;20(12). Wang XY, Qin YY. Long non-coding RNAs in biology and female reproductive disorders. Front Biosci (Landmark Ed). 2019 Mar 1;24:750-764. Henriques MC, Loureiro S, Fardilha M, Herdeiro MT. Exposure to mercury and human reproductive health: A systematic review. Reprod Toxicol. 2019 Apr;85:93-103. Amjadi F, Mehdizadeh M, Ashrafi M, et al. Distinct changes in the proteome profile of endometrial tissues in polycystic ovary syndrome compared with healthy fertile women.
    [Show full text]